SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (365)2/3/1999 9:22:00 AM
From: Mike McFarland  Read Replies (1) of 613
 
Henry, looks like Incyte came in with a nickle
when 0.20 was expected...yet I see this in the
PR
The net income for the quarter and year ended December 31, 1998
were impacted by the ramp up in expenses related to the genomic
sequencing and single nucleotide polymorphism (SNP) discovery
programs previously attributed to the Incyte Genetics business unit.
Excluding the impact of this business unit, net income would have
been $6.9 million or diluted earnings per share of $0.23 for the
quarter ended December 31, 1998.

So what do you make of all that--if it dips a bit more
early today perhaps a buying op? Do you follow incy,
I'd ask Rocketman, but I saw you were online etc...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News